Upstream Bio Inc (NASDAQ:UPB) shares, rose in value, with the stock price up by 4.28% to the previous day’s close as strong demand from buyers drove the stock to $8.78.
Actively observing the price movement in the last trading, the stock closed the session at $8.42, falling within a range of $8.13 and $8.92. Referring to stock’s 52-week performance, its high was $29.46, and the low was $5.14. On the whole, UPB has fluctuated by 2.69% over the past month.
With the market capitalization of Upstream Bio Inc currently standing at about $470.97 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-11.
The stock’s technical analysis shows that the price of UPB currently trading nearly 25.02% and 13.35% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.18, while the 7-day volatility ratio is showing 11.61% which for the 30-day chart, stands at 12.08%. Furthermore, Upstream Bio Inc (UPB)’s average true range (ATR) is 0.86.
Data on historical trading for Upstream Bio Inc (NASDAQ:UPB) indicates that the trading volumes over the past 10 days have averaged 0.32 and over the past 3 months, they’ve averaged 258.83K. According to company’s latest data on outstanding shares, there are 53.60 million shares outstanding.
Nearly 64.29% of Upstream Bio Inc’s shares belong to company insiders and institutional investors own 40.22% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.9 million shares as on 2025-03-31, resulting in a short ratio of 16.06. The stock has fallen by -46.59% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the UPB stock heading into the next quarter.
